While several molecular markers that are used to evaluate the development and prognosis of bladder cancer have been studied, the limited value of these established markers has created the need for ...

Armando, a 71-year-old with an active lifestyle, was midway through a round of golf when a strange sensation crept into his ...

The growing sophistication of tumor molecular profiling has helped to slowly transition oncologic care toward a more personalized approach in different tumor types, including in bladder cancer. The ...

A new report dives into the evolving clinical trial landscape and transformative therapies changing lives for bladder cancer ...

Financially, UroGen has a market cap of $464mn and a cash runway of 8-9 quarters, despite facing patent challenges from Teva.

under evaluation for hematuria (a common symptom of bladder cancer) or with a history of urothelial cancer were retrospectively analyzed. All patients underwent cystoscopy within 6 months of the ...

Trial findings show long-term recurrence-free survival in patients with low-grade upper tract urothelial cancer treated with ...

The company’s products, all branded Cxbladder, are a new class of bladder cancer detection and management tests that detect urothelial cancers including those in the upper urinary tract and ...

MRI scan could fast-track patients for bladder cancer treatment, study finds - An MRI instead of a surgical procedure helped ...

Bladder cancer is a cancer that develops in the bladder. It usually begins in the cells that line the inside of your bladder.

Rik Bryan, Professor in Urothelial Cancer Research and Director of the Bladder Cancer Research Centre at the University of Birmingham and first author of the study said: "Bladder cancer is a ...

Jan. 15, 2025 — Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research suggests that initial MRI ... Oct. 9, 2024 — How ...